Influenza A Virus, H3N2 Subtype
"Influenza A Virus, H3N2 Subtype" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subtype of INFLUENZA A VIRUS comprised of the surface proteins hemagglutinin 3 and neuraminidase 2. The H3N2 subtype was responsible for the Hong Kong flu pandemic of 1968.
Descriptor ID |
D053122
|
MeSH Number(s) |
B04.820.545.405.400.300
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Influenza A Virus, H3N2 Subtype".
Below are MeSH descriptors whose meaning is more specific than "Influenza A Virus, H3N2 Subtype".
This graph shows the total number of publications written about "Influenza A Virus, H3N2 Subtype" by people in this website by year, and whether "Influenza A Virus, H3N2 Subtype" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 0 | 1 |
2003 | 1 | 0 | 1 |
2006 | 0 | 2 | 2 |
2007 | 6 | 0 | 6 |
2008 | 2 | 3 | 5 |
2009 | 1 | 3 | 4 |
2010 | 4 | 2 | 6 |
2011 | 2 | 0 | 2 |
2012 | 2 | 0 | 2 |
2013 | 3 | 0 | 3 |
2014 | 0 | 1 | 1 |
2015 | 2 | 1 | 3 |
2016 | 1 | 0 | 1 |
2017 | 2 | 1 | 3 |
2018 | 1 | 1 | 2 |
2019 | 1 | 0 | 1 |
2020 | 1 | 3 | 4 |
2021 | 0 | 4 | 4 |
2022 | 0 | 3 | 3 |
2023 | 0 | 4 | 4 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Influenza A Virus, H3N2 Subtype" by people in Profiles.
-
The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial. Clin Infect Dis. 2024 Jan 25; 78(1):217-226.
-
Lack of neutralizing antibodies against influenza A viruses in adults during the 2022/2023 winter season - a serological study using retrospective samples collected in Hong Kong. Int J Infect Dis. 2023 Oct; 135:1-4.
-
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season. Clin Infect Dis. 2023 04 17; 76(8):1358-1363.
-
Influenza Vaccine Effectiveness Among Children: 2011-2020. Pediatrics. 2023 04 01; 151(4).
-
Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
-
Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018. J Infect Dis. 2022 08 12; 226(1):91-96.
-
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). Clin Infect Dis. 2022 04 28; 74(8):1329-1337.
-
Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel. J Infect Dis. 2022 03 02; 225(5):891-902.
-
Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated With B/Victoria Viruses, 2019-2020. Clin Infect Dis. 2021 08 16; 73(4):e947-e954.
-
Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). J Infect Dis. 2021 06 15; 223(12):2062-2071.